Životopis obrazac HRZZ - labp.biotech.uniri.hrlabp.biotech.uniri.hr/files/CV Josic.pdf · Životopis_obrazac_HRZZ ©hrzz 3 1981-1991. – Medicinska biokemija, preddiplomska, dodiplomska,

Životopis_obrazac_HRZZ

©hrzz

1

Životopis HRZZ obrazac

OSOBNI PODATCI

Ime i prezime Djuro Josić

Titula Prof. dr. sci.

Godina i ustanova stjecanja doktorata

1981. Technische Universität Berlin, Njemačka

Adresa Trg braće Mažuranića 10, HR 51000 Rijeka

Telefon 001 401 444 4427

Telefaks 001 401 793 8908

E-adresa [email protected]

Osobna mrežna stranica

Državljanstvo Hrvatsko

Datum i mjesto rođenja 14.12.1948. Gibarac

RADNO ISKUSTVO

1

(KRONOLOŠKI)

Datumi (od – do) 2011.-

Ustanova zaposlenja Sveučilište u Rijeci, Odjel za biotehnologiju

Naziv radnog mjesta Redoviti Profesor

Područje rada Proteomika u biotehnologiji

Datumi (od – do) 2003.-2010.

Ustanova zaposlenja RHODE ISLAND HOSPITAL & Brown University, Providence, RI, USA

Naziv radnog mjesta Direktor i profesor

Područje rada Proteomika

Datumi (od – do) 1991.-2003.

Ustanova zaposlenja Octapharma, Vienna, Austrija

Naziv radnog mjesta Šef istražvanja i razvoja

Područje rada Uspostavljanje istraživčke grupe i laboratorija. Razvoj novih proizvoda.

Datumi (od – do) 1990.-1991.

Ustanova zaposlenja Kompanija “DR. HERBERT KNAUER”, Berlin, Njemačka

Naziv radnog mjesta Šef istraživanja i razvoja

Područje rada Medicinska kemija i biokemija

Datumi (od – do) 1988.-1990.

Ustanova zaposlenja Kompanija “DR. HERBERT KNAUER”, Berlin, Njemačka

Naziv radnog mjesta Znanstveni suradnik

Područje rada Razvoj metoda za izolaciju i identifikaciju membranskih proteina

ŠKOLOVANJE

2

(KRONOLOŠKI)

Datum 1966.-1971.

Mjesto Sveučiliste u Zagrebu

Ustanova Tehnološki fakultet, Biotehnološki odjel

Zvanje Diplomirani inženjer biotehnologije

Datum 1973.-1977.

1,2,3 Molimo po potrebi dodajte redove kako biste unijeli sve podatke sve podatke u dokumentu navesti kronološki - od najnovijeg prema najstarijem


©hrzz

2

Mjesto Sveučilište u Zagrebu

Ustanova Prirodnslovno-matematički fakultet

Zvanje Magistar prirodnih znanosti, biokemija

Datum 1977.-1981.

Mjesto Berlin, Njemačka

Ustanova Technische Universität Berlin

Zvanje Doktor biotehnologije

Datum 1992.


Ustanova Freie Universität Berlin

Zvanje Docent

USAVRŠAVANJE

(KRONOLOŠKI)

Godina 1983.-1985.

Mjesto Bethesda, MD, USA

Ustanova National Institute of Health

Područje Biokemija, medicinska biokemija, biotehnologija

Godina 1981.-1989.


Ustanova Institut za molekularnu biologiju i biokemiju, Freie Universität Berlin

Područje Razvoj kromatografskih nosača za razdvajanje biopolimera

JEZICI

MATERINSKI JEZIK Hrvatski

ENGLESKI JEZIK

Govori Živio u USA Piše Publicira

Čita Evaluator

DRUGI STRANI JEZICI3

Jezik Njemački

Govori Živio u govornom području

Piše Izvrsno

Čita Izvrsno

ZNANSTVENI I DRUGI PROJEKTI

(KRONOLOŠKI; VOĐENJE I SUDJELOVANJE; IZVOR FINANCIRANJA)

1986.-1988., Razvoj materijala za kromatografiju, sudjelovanje, Ministarstvo znanosti SR Njemacke

1998.-2000. i 2000.-2002. Razvoj novih procesa za izolaciju terapeutskih proteina iz humane plazme, voditelj dvaju projekata, Europske Unije i Ministarstva znanosti Republike Austrije

2002.-2007. i 2009.-2011. Center for Biochemical Research Excellence, sudjelovanje, Direktor Proteomics Core, Vlada USA, National Institute of Health

2010. – Imaging Mass Spectrometry, voditelj, Vlada USA, National Institute of Health

2010., 2011. – Osnivanje laboratorija za analitičku biotehnologiju pri Odjelu za Biotehnologiju Sveučilista u Rijeci, voditelj (Projekt «Povratnik»), NZZ, Hrvatska.

NASTAVNA DJELATNOST

(KRONOLOŠKI; PREDDIPLOMSKA,DODIPLOMSKA, DIPLOMSKA, POSLIJEDIPLOMSKA NASTAVA )


©hrzz

3

1981-1991. – Medicinska biokemija, preddiplomska, dodiplomska, Freie Universität Berlin, Njemačka

1991.-2003. – Analitička biokemija, preddiplomska, dodiplomska, diplomska i poslijediplomska, Freie Universität Berlin, Njemačka, Univerza v Ljubljani, Slovenija i Sveučilište u Zagrebu, Hrvatska

2001-2011 – Proteomika – Poslijediplomska nastava, Brown University, Providence, RI, USA

MENTORSTVO OBRANJENIH DOKTORSKIH DISERATCIJA I MAGISTARSKIH RADOVA

I PODIZANJE ZNANSTVENOGA POMLATKA (KRONOLOŠKI)

Postdoktorandi

1. Michael Raps (1989-1991)

2. Klemens Loester (1994-1995)

3. Christoph Kannicht (1996-1999)

4. Ales Strancar (1996 – 1998)

5. Milos Barut (2000-2002)

6. Karmen Branović (2001-2002)

7. Lulu Cao (2009-)

8. Marijana Ručević (2010-)

Doktorandi

1. Wolfgang Schuett (1985 – 1988)

2. Katrin Zailinger (1988- 1992)

3. Yow-Pin Lim (1987 – 1990), Freie Universität Berlin

4. Klemens Loester (1990-1993)

5. Katharina Poeck (1995-1998)

6. Katharina Linnemayr (1997-1999)

7. Roman Necina (1995-1998)

8. Ales Strancar (1992 – 1996), Univerza v Ljubljani

9. Ales Podgornik (1996-1999)

10. Michaela Simonovska-Skrt (1999-2002)

11. Milos Barut (1997-2000)

12. Janja Luksa (1994-1997), Univerza v Ljubljani

13. Karmen Branović (1998-2001), Sveučiliste u Zagrebu

14. Marijana Ručević (2007), Sveučiliste u Zagrebu

15. Erica Lawson (2003-2008), Brown University

16. Martina Šrajer Gajdošik (2010), Sveučiliste u Osijeku i Sveučiliste u Zagrebu

Magistarski i diplomski radovi

1. Jurij Meiller (1987)

2. Ralf Habermann (1988)

3. Katrin Zeilinger (1988)

4. Oliver Baum (1989), Freie Universität Berlin

5. Janja Luksa (1993), Univerza v Ljubljani

6. Rainer Hahn (1997)

7. Guenther Iberer (1998)

8. Karin Pflegerl (1998)

9. Mihaela Simonovska-Skrt (1997)

10. Tadej Cepelnik (2002)

11. Patrik Rosker (2011), Univerza v Novoj Gorici

GOSTOVANJE NA STRANIM ZNANSTVENIM USTANOVAMA

(KRONOLOŠKI; BORAVCI DUŽI OD 3 MJESECA)

1983.-1985. National Institute of Health, Bethesda, Maryland, USA

1991. Rhode Island Hospital and Brown University, Providence, RI, USA


©hrzz

4

NAGRADE I PRIZNANJA

(KRONOLOŠKI)

1996. Naslovni profesor medicinske biokemije, Freie Universität Berlin,

1998. Počasni gradjanin grada Slavonskog Broda

1998. Pohvala grada Beča organizacija Simpozija

1996, 1998, 2000. – Octapharma Pharmaceutika, Beč, nagrada za razvoj novog preparata

2001. Naslovni profesor, Prehrambeno biotehnološki fakultet, Zagreb

2004. Firma BIA Separations, razvoj tehnologije monolita

2009. BIA, godišnjica tvrtke i simpozij

ORGANIZACIJSKE VJEŠTINE I KOMPETENCIJE (KRONOLOŠKI; ORGANIZACIJA DOMAĆIH I MEĐUNARODNIH ZNANSTVENIH DOGAĐANJA )

1998. Simpozij ISPPP 2008 u Beču (Organizacijski i znanstveni odbor)

2000. Simpozij ISPPP 2010 u Ljubljani (Organizacijski i znanstveni odbor, Voditelj)

2002.-2008. Clan «Scientific Committee»za ISPPP simpozije

2005. do sada, znanstvena organizacija simpozija i postdoktorske škole «Monoliths» u Portorožu, Slovenija

1998, 2000, 2004, 2006, 2007, 2008. Gostujući urednik specijalnih izdanja znanstvenog časopisa Journal of Chromatography A

ČLANSTVA U ZNANSTVENIM ORGANIZACIJAMA I TIJELIMA

(KRONOLOŠKI; DOMAĆE I MEĐUNARODNE ORGANIZACIJE I TIJELA)

Society of Regenerative Medicine

American Chemical Society

European Society of Biotechnology

MASSEP - Massachusetts Separation Society

Germal Biochemical Society

POVJERENSTVA, ODBORI I RADNE SKUPINE

(KRONOLOŠKI; DOMAĆI I MEĐUNARODNI)

od 1998. Organizacijski komitet ISPPP

od 2003. Organizacija znanstvenih skupova COBRE Center for Cancer Research Development

od 2005. Organizacijski i znanstveni komitet «Monoliths»

2003. – 2007. Član upravnog odbora Njemackog društva za regenerativnu medicinu


©hrzz

5

ZNANSTVENI RADOVI (KRONOLOŠKI; ZNANSTVENE KNJIGE, DOMAĆI I MEĐUNARODNI ZNANSTVENI ČASOPISI, ZBORNICI RADOVA DOMAĆIH I MEĐUNARODNIH

ZNANSTVENIH SKUPOVA; POTREBNO JE NAVJESTI I NJIHOV ODJEK) Web of Science EXPORT DATE: October 21, 2011

1. Đuro Josić, Discovery of diagnostic and prognostic biomarkers – high throughput proteomic analysis of urine and blood plasma samples of patients undergoing image-guided tumor ablation, 2nd International Conference on Proteomics & Bioinformatics, July 2-4, 2012 Embassy Suites Las Vegas, USA, plenarno predavanje

2. Lucas Breen, Lulu Cao, Kirsten Eom, Martina Šrajer Gajdošik, Lila Camara, Jasminka Giacometti, Damian E. Dupuy, Đuro Josić, High-throughput fractionation of human plasma for fast enrichment of low- and high-abundance proteins, Blood Transfusion 10 (2012) S86-96.

3. Đuro Josić, James Clifton, Martina Šrajer Gajdošik, «Sample Displacement Chromatography of Peptides and Proteins», J. Chromatogr.A, 1239 (2012) 1-9.

4. Martina Šrajer Gajdošik, James Clifton, Lucas Breen, Feilei Huang, Lulu Cao, Douglas Hixson, Đuro Josić, «Sample Displacement Chromatography of Proteins in Hydrophobic Interaction Mode», Electrophoresis (2012) accepted for publication.

5. Giacometti, J, Josic, Dj., Fidel Toldrá and Leo M. L. Nollet, (Eds.), Microbial proteomics for food safety, in " Proteomics in foods. Principles and applications", Humana Press (Springer), (2012) New York, USA, in press.

6. Josić, Dj., Therapeutic plasma proteins – Application of proteomics in process optimization, validation and analyzis of the final product», Odjel za kemiju, Johannes Gutenberg Universitae Mainz, Njemacka («Sonderfirschungsbereich 625»), Mainz, 17. siječnja 2012., invited lecture

7. Josić, Dj., Mueller, E.; Srajer Gajdosik, M.; «Sample displacement chromatography, use of this method for high throughput sample preparation», Međunarodni simpozij «Monoliths», Portorož, Slovenija, June 1-6, 2012. invited lecture

8. Josić, Dj.; Breen, L.; Srajer Gajdosik, M.; «High-throughput sample preparation», međunarodni simpozij ISPPP 2012, rujan 2012, Istanbul, Turska, invited lecture

9. Josić, Dj., Selectivity of porous, non-porous and monolithic supports in hydrophobic-interaction chromatography under overloading conditions, Invited lecture, HIC/RPC Int. Symposium, Estoril, Portugal 2011 – invited lecture

10. Josić, Dj., Egbert Müller, Sample displacement chromatography on high capacity porous and monolithic supports – an alternative for purification of high and low abundance proteins, Lecture, Int. Symposium Plasma Protein Biotechnology PPB 2011, Paphos, Cyprus 2011. invited lecture

11. Josić, Dj., Use of proteomic in food technology and biotechnology, Invited lecture, 7th International Congress of Food Technologists, Biotechnologists and Nutricionists, Opatija, Croatia 2011. invited lecture

12. Josić, Dj., High throughput sample preparation for HPLC and MS, Invited lecture, MSBM, Mass Spectrometry in Biotechnology and Medicine, Dubrovnik, Croatia 2011. invited lecture

13. Josić, Dj., Membrane proteins and their changes during carcinogenesis, Invited lecture, MSBM, Mass Spectrometry in Biotechnology and Medicine, Dubrovnik, Croatia 2011. invited lecture

14. Josić, Dj., Egbert Müller, Marina Srajer Gajdosik, Sample displacement chromatography, ISPPP 2011, International Symposium on Chromatography of Proteins, Polypeptides and Polynucleotides, Alexandria, VA, USA, October 2011. invited lecture

15. Marijana Rucevic (presenting), Lucas Breen, Feilei Huang, Lulu Cao, Douglas Hixson, Josić, Dj., (senior author), “Mass Spectrometry-based Proteomics of Aristolochic Acids Induced Nephrotoxicity in Experimental Animal Model”. Lecture, Annual Symp. American Society Mass Spectrometry, Denver, CO, USA, June 2011. invited lecture

16. Pučić, M., Knežević, A., Vidič, J., Adamczyk, B., Novokmet, M., Polašek, O., Gornik, O., Šupraha-Goreta, S., Wormald, M. R., Redžić, I., Campbell, H., Wright, A., Hastie, N. D., Wilson, J. F., Rudan, I., Wuhrer, M., Rudd, P. M., Josić, Dj., and Lauc, G., High throughput isolation and glycosylation analysis of IgG – variability and heritability of the IgG glycome in two isolated human populations, Mol. Cell. Proteomics 2012, in press.

17. Srajer Gajdosik, M., Clifton, J., Josic, Dj., Sample displacement chromatography of proteins and peptides, Journal of Chromatography, 2012,. submitted.

18. Josic, Dj., Breen, L., Clifton, J., Srajer Gajdosik, M., Gaso Sokac, D., Rucevic, M., Müller, E., Separation of proteins from human plasma by sample displacement chromatography in hydrophobic interaction mode, Electrophoresis, 2012, submitted


©hrzz

6

19. Gaso-Sokac, D., Kovac, S., Josic, Dj., Use of proteomics methodology in optimization of processing parameters and quality control of food of animal origin, Food Technol. Biotechnol. 49 (2011) 397-412. Cited 0 time. Impact factor 0.976

20. Brgles, M., Clifton, J., Walsh, R. Huang, F., Rucević, M., Cao, L., Hixson, D., Müller, E., Josic, Dj., Selectivity of monolithic supports under overloading conditions and their use for separation of human plasma and isolation of low abundance proteins, J. Chromatogr. A 1218 (2011) 2389-2395. Cited 1 time. Impact factor 4.194

21. Josic, Dj., Hixson, D., (Eds.), Liver Proteomics, in "Methods of Molecular Biology", Humana Press (Springer), (2010) New York, USA, in press.

22. Sedic, M Pavelic, SK Cindric, M Vissers, JPC Peronja, M Josic, D Cuk, M Fumic, K Pavelic, K Baric, Plasma biomarker identification in S-adenosylhomocysteine hydrolase deficiency (2011) ELECTROPHORESIS, 32 (15) 1570-1575. Cited 0 time. Impact factor 3.569

23. Clifton, J, Huang, FL, Rucevic, M, Cao, LL, Hixson, D, Josic, D (2011) Protease inhibitors as possible pitfalls in proteomic analyses of complex biological samples, JOURNAL OF PROTEOMICS, 74 (7) 935-941. Cited 0 time. Impact factor 5.074

24. Rucevic, M, Hixson, D, Josic, D (2011) Mammalian plasma membrane proteins as potential biomarkers and drug targets, ELECTROPHORESIS 32(13) 1549-1564. Cited 0 time. Impact factor 3.569

25. Gaso-Sokac, D, Kovac, S, Clifton, J, Josic, D (2011) Therapeutic plasma proteins - application of proteomics in process optimization, validation, and analysis of the final product, ELECTROPHORESIS 32 (10) 1104-1117. Cited 1 time. Impact factor 3.569

26. Brgles, M, Clifton, J, Walsh, R, Huang, FL, Rucevic, M, Cao, LL, Hixson, D, Muller, E, Josic, D (2010) Selectivity of monolithic supports under overloading conditions and their use for separation of human plasma and isolation of low abundance proteins, JOURNAL OF CHROMATOGRAPHY A, 4th Summer School of Monolith Technology for Biochromatography, Bioconversion and Phase State Synthesis, Portoroz, Slovenia MAY 30-JUN 02, 2010. Cited 1 time. Impact factor 4.194

27. Gaso-Sokac, D., Josic, D. The role of proteomics in plasma fractionation and quality control of plasma-derived therapeutic proteins (2010) Blood Transfusion, 8 (SUPPL. 3), pp. s86-s91. Cited 1 time. Impact factor 2.515

28. Chuang, C., Lin, S.-H., Huang, F., Pan, J., Josic, D., Yu-Lee, L.-Y. Acetylation of RNA processing proteins and cell cycle proteins in mitosis (2010) Journal of Proteome Research, 9 (9), pp. 4554-4564. Cited 1 time. Impact factor 5.460

29. Josic, D., Kovac, S. Reversed-phase high performance liquid chromatography of proteins (2010) Current Protocols in Protein Science, (SUPPL. 61), pp. 8.7.1-8.7.22.

30. Gašo-Sokač, D., Kovač, S., Josić, D. Application of proteomics in food technology and food biotechnology: Process development, quality control and product safety (2010) Food Technology and Biotechnology, 48 (3), pp. 284-295. Cited 0 time. Impact factor 0.976

31. Müller, E., Josic, D., Schröder, T., Moosmann, A. Solubility and binding properties of PEGylated lysozyme derivatives with increasing molecular weight on hydrophobic-interaction chromatographic resins (2010) Journal of Chromatography A, 1217 (28), pp. 4696-4703. Cited 3 time. Impact factor 4.194

32. Aliotta, J.M., Pereira, M., Johnson, K.W., de Paz, N., Dooner, M.S., Puente, N., Ayala, C., Brilliant, K., Berz, D., Lee, D., Ramratnam, B., McMillan, P.N., Hixson, D.C., Josic, D., Quesenberry, P.J. Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription (2010) Experimental Hematology, 38 (3), pp. 233-245. Cited 11 times. Impact factor 3.198

33. Josic, D. Foreword (2010) Journal of Chromatography A, 1217 (2), p. 183. Impact factor 4.194

34. Josic, D. 6th Hydrophobic interaction chromatography/reversed-phase liquid chromatography bioseparation conference. Foreword. (2010) Journal of chromatography. A, 1217 (2), p. 183. Impact factor 4.194

35. Clifton, J., Huang, F., Gaso-Sokac, D., Brilliant, K., Hixson, D., Josic, D. Use of proteomics for validation of the isolation process of clotting factor IX from human plasma (2010) Journal of Proteomics, 73 (3), pp. 678-688. Cited 6 times. Impact factor 5.074

36. Clifton, J.G., Huang, F., Kovac, S., Yang, X., Hixson, D.C., Josic, D. Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates (2009) Electrophoresis, 30 (20), pp. 3636-3646. Cited 11 times. Impact factor 3.569

37. Yang, X., Clifton, J., Huang, F., Kovac, S., Hixson, D.C., Josic, D. Proteomic analysis for process development and control of therapeutic protein separation from human plasma (2009) Electrophoresis, 30 (7), pp. 1185-1193. Cited 10 times. Impact factor 3.569


©hrzz

7

38. Huang, F., Clifton, J., Yang, X., Rosenquist, T., Hixson, D., Kovac, S., Josic, D. SELDI-TOF as a method for biomarker discovery in the urine of aristolochic-acid-treated mice (2009) Electrophoresis, 30 (7), pp. 1168-1174. Cited 8 times. Impact factor 3.569

39. Roser, M., Josic, D., Kontou, M., Mosetter, K., Maurer, P., Reutter, W. Metabolism of galactose in the brain and liver of rats and its conversion into glutamate and other amino acids (2009) Journal of Neural Transmission, 116 (2), pp. 131-139. Cited 1 time. Impact factor 2.597

40. Kovac, S., Yang, X., Huang, F., Hixson, D., Josic, D. Proteomics as a tool for optimization of human plasma protein separation (2008) Journal of Chromatography A, 1194 (1), pp. 38-47. Cited 12 times. Impact factor 4.194

41. Josic, D., Clifton, J.G., Kovac, S., Hixson, D.C. Membrane proteins as diagnostic biomarkers and targets for new therapies (2008) Current Opinion in Molecular Therapeutics, 10 (2), pp. 116-123. Cited 8 times. Impact factor 4.023

42. Josic, D., Kovač, S. Application of proteomics in biotechnology - Microbial proteomics (2008) Biotechnology Journal, 3 (4), pp. 496-509. Cited 10 times. Impact factor 3.225

43. Josic, D. Foreword (2008) Journal of Chromatography A, 1177 (2), p. 199. Impact factor 4.194

44. Josic, D., Clifton, J.G. Mammalian plasma membrane proteomics (2007) Proteomics, 7 (16), pp. 3010-3029. Cited 46 times. Impact factor 4.815

45. Clifton, J.G., Li, X., Reutter, W., Hixson, D.C., Josic, D. Comparative proteomics of rat liver and Morris hepatoma 7777 plasma membranes (2007) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 849 (1-2), pp. 293-301. Cited 19 times. Impact factor 2.971

46. Josic, D., Clifton, J.G. Use of monolithic supports in proteomics technology (2007) Journal of Chromatography A, 1144 (1), pp. 2-13. Cited 38 times. Impact factor 4.194

47. Rucevic, M., Clifton, J.G., Huang, F., Li, X., Callanan, H., Hixson, D.C., Josic, D. Use of short monolithic columns for isolation of low abundance membrane proteins (2006) Journal of Chromatography A, 1123 (2), pp. 199-204. Cited 19 times. Impact factor 4.194

48. Clifton, J.G., Brown, M.K., Huang, F., Li, X., Reutter, W., Hofmann, W., Hixson, D.C., Josic, D. Identification of members of the annexin family in the detergent-insoluble fraction of rat Morris hepatoma plasma membranes (2006) Journal of Chromatography A, 1123 (2), pp. 205-211. Cited 8 times. Impact factor 4.194

49. Josic, D., Clifton, J., Wang, A., Li, X., Hixson, D., Dong, H., Rosenquist, T.,(2006) Proteomics of aristolochic acid nephropathy, Coll. Anthropol. 30, (S1), 28. No citation

50. Lawson, E.L., Clifton, J.G., Huang, F., Li, X., Hixson, D.C., Josic, D. Use of magnetic beads with immobilized monoclonal antibodies for isolation of highly pure plasma membranes (2006) Electrophoresis, 27 (13), pp. 2747-2758. Cited 47 times. Impact factor 3.569

51. Josic, D., Brown, M.K., Huang, F., Lim, Y.-P., Rucevic, M., Clifton, J.G., Hixson, D.C. Proteomic characterization of inter-alpha inhibitor proteins from human plasma (2006) Proteomics, 6 (9), pp. 2874-2885. Cited 26 times. Impact factor 4.815

52. Plematl, A., Demelbauer, U.M., Josic, D., Rizzi, A. Determination of the site-specific and isoform-specific glycosylation in human plasma-derived antithrombin by IEF and capillary HPLC-ESI-MS/MS (2005) Proteomics, 5 (15), pp. 4025-4033. Cited 11 times. Impact factor 4.815

53. Josic, D., Brown, M.K., Huang, F., Callanan, H., Ručević, M., Nicoletti, A., Clifton, J., Hixson, D.C. Use of selective extraction and fast chromatographic separation combined with electrophoretic methods for mapping of membrane proteins (2005) Electrophoresis, 26 (14), pp. 2809-2822. Cited 37 times. Impact factor 3.569

54. Demelbauer, U.M., Plematl, A., Josic, D., Allmaier, G., Rizzi, A. On the variation of glycosylation in human plasma derived antithrombin (2005) Journal of Chromatography A, 1080 (1 SPEC. ISS.), pp. 15-21. Cited 20 times. Impact factor 4.194

55. Josić, D. Journal of Chromatography A: Foreword (2005) Journal of Chromatography A, 1065 (1), p. 1. Impact factor 4.194

56. Lim, Y.-P., Josic, D., Callanan, H., Brown, J., Hixson, D.C. Affinity purification and enzymatic cleavage of inter-alpha inhibitor proteins using antibody and elastase immobilized on CIM monolithic disks (2005) Journal of Chromatography A, 1065 (1), pp. 39-43. Cited 15 times. Impact factor 4.194

57. Demelbauer, U.M., Plematl, A., Kremser, L., Allmaier, G., Josic, D., Rizzi, A. Characterization of glyco isoforms in plasma-derived human antithrombin by on-line capillary zone electrophoresis-electrospray ionization-quadrupole ion trap-mass spectrometry of the intact glycoproteins (2004) Electrophoresis, 25 (13), pp. 2026-2032. Cited 33 times. Impact factor 3.569


©hrzz

8

58. Kremser, L., Brükner, A., Heger, A., Grunert, T., Buchacher, A., Josic, D., Allmaier, G., Rizzi, A. Characterization of antihrombin III from human plasma by two-dimensional gel electrophoresis and capillary electrophoretic methods (2003) Electrophoresis, 24 (24), pp. 4282-4290. Cited 13 times. Impact factor 3.569

59. Josić, D. Chapter 18 Separation of Peptides and Proteins (2003) Journal of Chromatography Library, 67 (C), pp. 389-415. Cited 1 time.

60. Ahrer, K., Buchacher, A., Iberer, G., Josic, D., Jungbauer, A. Analysis of aggregates of human immunoglobulin G using size-exclusion chromatography, static and dynamic light scattering (2003) Journal of Chromatography A, 1009 (1-2), pp. 89-96. Cited 31 times. Impact factor 4.194

61. Josic, D., Hoffer, L., Buchacher, A. Preparation of vitamin K-dependent proteins, such as clotting factors II, VII, IX and X and clotting inhibitor Protein C (2003) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 790 (1-2), pp. 183-197. Cited 10 times. Impact factor 2.971

62. Branović, K., Buchacher, A., Barut, M., Strancar, A., Josic, D. Application of semi-industrial monolithic columns for downstream processing of clotting factor IX (2003) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 790 (1-2), pp. 175-182. Cited 23 times. Impact factor 2.971

63. Belgacem, O., Buchacher, A., Pock, K., Josic, D., Sutton, C., Rizzi, A., Allmaier, G. Molecular mass determination of plasma-derived glycoproteins by ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with internal calibration (2002) Journal of Mass Spectrometry, 37 (11), pp. 1118-1130. Cited 17 times. Impact factor 3.289

64. Iberer, G., Schwinn, H., Josic, D., Jungbauer, A., Buchacher, A. Continuous purification of a clotting factor IX concentrate and continuous regeneration by preparative annular chromatography (2002) Journal of Chromatography A, 972 (1), pp. 115-129. Cited 8 times. Impact factor 4.194

65. Saenko, E.L., Ananyeva, N., Kouiavskaia, D., Schwinn, H., Josic, D., Shima, M., Hauser, C.A.E., Pipe, S. Molecular defects in coagulation factor VIII and their impact on factor VIII function (2002) Vox Sanguinis, 83 (2), pp. 89-96. Cited 6 times. Impact factor 3.292

66. Josic, Dj., Barut, M. (2002), Monolithic Chromatography Media in „Chromatographic Packing Materials“ (Eriksson, K.-O., Henry, M.P., Eds.), MML Series, Citus Ltd., London

67. Heger, A., Grunert, T., Schulz, P., Josic, D., Buchacher, A. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography (2002) Thrombosis Research, 106 (2), pp. 157-164. Cited 15 times. Imapact factor 2.372

68. Yang, S., Lim, Y.-P., Zhou, M., Salvemini, P., Schwinn, H., Josic, D., Koo, D.J., Chaudry, I.H., Wang, P. Administration of human inter-α-inhibitors maintains hemodynamic stability and improves survival during sepsis (2002) Critical Care Medicine, 30 (3), pp. 617-622. Cited 32 times. Impact factor 6.254

69. Saenko, E., Kannicht, C., Loster, K., Sarafanov, A., Khrenov, A., Kouiavskaia, D., Shima, M., Ananyeva, N., Schwinn, H., Gruber, G., Josic, D. Development and applications of surface plasmon resonance-based von Willebrand factor-collagen binding assay (2002) Analytical Biochemistry, 302 (2), pp. 252-262. Cited 4 times. Impact factor 3.236

70. Khrenov, A., Sarafanov, A., Ananyeva, N., Kouiavskaia, D., Shima, M., Schwinn, H., Josic, D., Saenko, E. Molecular basis for different ability of low-density and high-density lipoproteins to support activity of the intrinsic Xase complex (2002) Thrombosis Research, 105 (1), pp. 87-93. Cited 5 times. Impact factor 2.372

71. Josić, D., Lim, Y.-P. Analytical and Preparative Methods for Purification of Antibodies (2001) Food Technology and Biotechnology, 39 (3), pp. 215-226. Cited 8 times. Impact factor 0.976

72. Iberer, G., Schwinn, H., Josić, D., Jungbauer, A., Buchacher, A. Improved performance of protein separation by continuous annular chromatography in the size-exclusion mode (2001) Journal of Chromatography A, 921 (1), pp. 15-24. Cited 18 times. Impact factor 4.194

73. Josić, D. Foreword: Journal of Chromatography A (2001) Journal of Chromatography A, 921 (1), p. 1. Impact factor 4.194

74. Josic, Dj., Buchacher, A. (2001), Application of Monoliths as Supports for Affinity Chromatography and Fast Enzymatic Conversion, J. Biochem. Biophys. Methods 49, 153-174. Cited 66 times. Impact factor 1.808

75. Lim, Y.-P., Josic, Dj. (2001) HPLC Purification of Antibodies in „HPLC of Biological Macromolecules, 2nd Edition“ (Gooding, K., Regnier, FE., Eds.), Marcel Dekker Inc., New York, 607-633.

76. 98. Josic, Dj. (2001), Affinity Chromatography of Proteins from Human Plasma Using Low Molecular Combinatorial Ligands, Kem. Ind. 50, 325-334.

77. Saenko, E., Sarafanov, A., Ananyeva, N., Behre, E., Shima, M., Schwinn, H., Josić, D. Comparison of the properties of phospholipid surfaces formed on HPA and L1 biosensor chips for the binding of the coagulation factor VIII (2001) Journal of Chromatography A, 921 (1), pp. 49-56. Cited 23 times. Impact factor 4.194


©hrzz

9

78. Pock, K., Buchacher, A., Rizzi, A., Josić, D. Characterization of clotting factor IX in plasma-derived preparations by electrophoretic techniques (2001) Journal of Chromatography A, 921 (1), pp. 57-67. Cited 4 times. Impact factor 4.194

79. Josic, D., Kannicht, C., Löster, K., Pock, K., Iberer, G., Buchacher, A. Vitronectin in clotting factor IX concentrates (2001) Haemophilia, 7 (3), pp. 250-257. Cited 11 times. Impact factor 2.364

80. Saenko, E., Josic, D., Stadler, M., Sarafanov, A., Lim, Y.-P., Shima, M., Ananyeva, N., Schwinn, H. Molecular modifications in factor VIII concentrates produced from different plasma pools (2001) Thrombosis Research, 101 (6), pp. 501-511. Cited 6 times. Impact factor 2.372

81. Josic, Dj., Stadler, M., Gruber, G., Kannicht, Ch., Schwinn, H. (2001), Process development of a highly purified, native Factor VIII/von Willebrand Factor concentrate, Downstream PPB 2001, 18-20.

82. Pflegerl, K., Hahn, R., Schallaun, E., Josic, D., Jungbauer, A. Quantification of plasma-derived blood coagulation factor VIII by real-time biosensor measurements (2001) Journal of Chromatography B: Biomedical Sciences and Applications, 752 (2), pp. 335-347. Cited 6 times. Impact factor 2.971

83. Josic, D., Buchacher, A., Jungbauer, A. Monoliths as stationary phases for separation of proteins and polynucleotides and enzymatic conversion (2001) Journal of Chromatography B: Biomedical Sciences and Applications, 752 (2), pp. 191-205. Cited 131 times. Impact factor 2.971

84. Buchacher, A., Iberer, G., Jungbauer, A., Schwinn, H., Josic, D. Continuous removal of protein aggregates by annular chromatography (2001) Biotechnology Progress, 17 (1), pp. 140-149. Cited 16 times. Impact factor 2.178

85. Amatschek, K., Necina, R., Hahn, R., Schallaun, E., Schwinn, H., Josić, D., Jungbauer, A. Affinity chromatography of human blood coagulation factor VIII on monoliths with peptides from a combinatorial library (2000) Journal of Separation Science, 23 (1), pp. 47-58. Cited 8 times. Impact factor 2.631

86. Hahn, R., Amatschek, K., Schallaun, E., Necina, R., Josic, D., Jungbauer, A. Performance of affinity chromatography with peptide ligands: Influence of spacer, matrix composition and immobilization chemistry (2000) International Journal of Bio-Chromatography, 5 (3), pp. 175-185. Cited 15 times. Impact factor 2.846

87. Branovic, K, Buchacher, A, Barut, M, Strancar, A, Josic, D (2000) Application of monoliths for downstream processing of clotting factor IX, JOURNAL OF CHROMATOGRAPHY A, 903 (1-2) 21-32. Cited 24 time. Impact factor 4.194

88. Josic, D, Hoffer, L, Buchacher, A, Schwinn, H, Frenzel, W, Biesert, L, Klocking, HP, Hellstern, R, Rokicka-Milewska, R, Klukowska, A (2000) Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity, THROMBOSIS RESEARCH 100 (5) 433-441. Cited 16 time. Impact factor 2.372

89. Podgornik, A., Barut, M., Strancar, A., Josic, D., Koloini, T. Construction of large-volume monolithic columns (2000) Analytical Chemistry, 72 (22), pp. 5693-5699. Cited 90 times. Impact factor 5.874

90. Saenko, E., Sarafanov, A., Greco, N., Shima, M., Loster, K., Schwinn, H., Josic, D. Erratum: Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes (Journal of Chromatography A (1999) 852 (59-71) PII: S0021967399004914) (2000) Journal of Chromatography A, 872 (1-2), p. 323. Cited 1 time. Impact factor 4.194

91. Amatschek, K., Necina, R., Hahn, R., Schallaun, E., Schwinn, H., Josić, D., Jungbauer, A. Affinity chromatography of human blood coagulation factor VIII on monoliths with peptides from a combinatorial library (2000) HRC Journal of High Resolution Chromatography, 23 (1), pp. 47-58. Cited 23 times. Impact factor 2.631

92. Barut, M., Podgornik, A., Podgornik, H., Štrancar, A., Josić, D., Mac Farlane, J.D. Fast separation of biomolecules using polymer-based monolithic supports (1999) American Biotechnology Laboratory, 17 (9), pp. 48-52. Cited 7 times.

93. Josić, D., Štrancar, A. Application of membranes and compact, porous units for the separation of biopolymers (1999) Industrial and Engineering Chemistry Research, 38 (2), pp. 333-342. Cited 61 times. Impact factor 2.071

94. Saenko, E.L., Loster, K., Josic, D., Sarafanov, A.G. Effect of von Willebrand factor and its proteolytic fragments on kinetics of interaction between the light and heavy chains of human factor VIII (1999) Thrombosis Research, 96 (5), pp. 343-354. Cited 8 times. Impact factor 2.372

95. Josić, D., Buchacher, A., Kannicht, C., Lim, Y.-P., Löster, K., Pock, K., Robinson, S., Schwinn, H., Stadler, M. Degradation products of factor VIII which can lead to increased immunogenicity (1999) Vox Sanguinis, 77 (SUPPL. 1), pp. 90-99. Cited 25 times. Impact factor 3.292

96. Pock, K., Rizzi, A., Josic, D. Use of high-resolution techniques for the characterization of clotting factor VIII (1999) Journal of Chromatography A, 852 (1), pp. 175-188. Cited 6 times. Impact factor 4.194


©hrzz

10

97. Saenko, E., Sarafanov, A., Greco, N., Shima, M., Loster, K., Schwinn, H., Josic, D. Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions: Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes (1999) Journal of Chromatography A, 852 (1), pp. 59-71. Cited 28 times. Impact factor 4.194

98. Hoffer, L., Schwinn, H., Josić, D. Production of highly purified clotting factor IX by a combination of different chromatographic methods (1999) Journal of Chromatography A, 844 (1-2), pp. 119-128. Cited 20 times. Impact factor 4.194

99. Josić, D., Pock, K. Development of Medical Products Based on Human Plasma (1999) Food Technology and Biotechnology, 37 (1), pp. 51-63. Impact factor 0.976

100. Linnemayr, K., Rizzi, A., Josic, D., Allmaier, G. Comparison of microscale cleaning procedures for (Glyco) proteins prior to positive ion matrix-assisted laser desorption ionization mass spectrometry (1998) Analytica Chimica Acta, 372 (1-2), pp. 187-199. Cited 8 times. Impact factor 4.310

101. Pock, K., Jungbauer, A., Kannicht, C., Löster, K., Buchacher, A., Josic, D. Electrophoretic analyses of clotting factor VIII concentrates (1998) Analytica Chimica Acta, 372 (1-2), pp. 219-229. Cited 6 times. Impact factor 4.310

102. Necina, R., Amatschek, K., Schallaun, E., Schwinn, H., Josic, D., Jungbauer, A. Peptide affinity chromatography of human clotting factor VIII. Screening of the vWF-binding domain (1998) Journal of Chromatography B: Biomedical Applications, 715 (1), pp. 191-201. Cited 19 times. Impact factor 2.971

103. Josić, D., Schwinn, H., Štrancar, A., Podgornik, A., Miloš Barut, Lim, Y.-P., Vodopivec, M. Use of compact, porous units with immobilized ligands with high molecular masses in affinity chromatography and enzymatic conversion of substrates with high and low molecular masses (1998) Journal of Chromatography A, 803 (1-2), pp. 61-71. Cited 55 times. Impact factor 4.194

104. Buchacher, A., Schulz, P., Choromanski, J., Schwinn, H., Josic, D. High-performance capillary electrophoresis for in-process control in the production of antithrombin III and human clotting factor IX (1998) Journal of Chromatography A, 802 (2), pp. 355-366. Cited 20 times. Impact factor 4.194

105. Josić, D., Horn, H., Schulz, P., Schwinn, H., Britsch, L. Size-exclusion chromatography of plasma proteins with high molecular masses (1998) Journal of Chromatography A, 796 (2), pp. 289-298. Cited 17 times. Impact factor 4.194

106. Josic, D., Stadler, M., Schwinn, H., Pock, K. The biochemical characterisation of several factor VIII concentrates (1997) Infusionstherapie und Transfusionsmedizin, 24 (4), p. 286. Impact factor 1.950

107. Löster, K., Josić, D. Analysis of protein aggregates by combination of cross-linking reactions and chromatographic separations (1997) Journal of Chromatography B: Biomedical Applications, 699 (1-2), pp. 439-461. Cited 14 times. Impact factor 2.971

108. Luksa, J, Josic, D, Kremser, M, Kopitar, Z, Milutinovic, S (1997) Pharmacokinetic behaviour of R-(+)- and S-(-)-amlodipine after single enantiomer administration, JOURNAL OF CHROMATOGRAPHY B, Symposium on New Achievements in Chromatography, OCT 08-10, 1996, OPATIJA, CROATIA, 703 (1-2) 185-193. Cited 29 times. Impact factor 2.971

109. Luksa, J, Josic, D, Podobnik, B, Furlan, B, Kremser, M (1997) Semi-preparative chromatographic purification of the enantiomers S-(-)-amlodipine and R-(+)-amlodipine RID B-5943-2008, JOURNAL OF CHROMATOGRAPHY B, Symposium on New Achievements on Chromatography, OCT 08-10, 1996, OPATIJA, CROATIA, 693 (2) 367-375. Cited 13 times. Impact factor 2.971

110. Josić, D., Schulz, P., Biesert, L., Hoffer, L., Schwinn, H., Kordis-Krapez, M., Strancar, A. Issues in the development of medical products based on human plasma (1997) Journal of Chromatography B: Biomedical Applications, 694 (2), pp. 253-269. Cited 14 times. Impact factor 2.971

111. Morfeld, F., Schütz, R., Josic, D., Schwinn, H. Manufacturing and down scaling process for a virus-inactivated pooled human plasma (1997) Drugs Made in Germany, 40 (3), pp. 91-93.

112. Štrancar, A., Koselj, P., Schwinn, H., Josic, D. Application of Compact Porous Disks for Fast Separations of Biopolymers and In-Process Control in Biotechnology (1996) Analytical Chemistry, 68 (19), pp. 3483-3488. Cited 83 times. Impact factor 5.287

113. Josic, D., Zeilinger, K. Membrane proteins (1996) Methods in Enzymology, 271, pp. 113-134. Cited 15 times. Impact factor 1.900

114. Morfeld, F., Schütz, R., Josic, D., Schwinn, H. Manufacturing and down scaling process for a virus-inactivated pooled human plasma (1996) Pharmazeutische Industrie, 58 (5), pp. 433-435. Cited 5 times. Impact factor 3.277


©hrzz

11

115. Fan, H., Josic, D., Lim, Y.-P., Reutter, W. cDNA cloning and tissue-specific regulation of expression of rat calcium- binding protein 65/67 - Identification as a homologue of annexin VI (1995) European Journal of Biochemistry, 230 (2), pp. 741-751. Cited 15 times. Impact factor 3.129

116. Luksa, J., Josic, D. Determination of cimetidine in human plasma by free capillary zone electrophoresis (1995) Journal of Chromatography B: Biomedical Applications, 667 (2), pp. 321-327. Cited 24 times. Impact factor 2.971

117. Biesert, L., Josic, D., Robinson, S., Helmich, B., Schwinn, H. Profile of a highly purified, double virus inactivated factor VII [EIGENSCHAFTEN EINES HOCHGEREINIGTEN, DOPPELT VIRUS-INAKTIVIERTEN FAKTOR-VII-KONZENTRATS] (1995) Hamostaseologie, 15 (1), pp. 49-53. Impact factor 0.780

118. Robinson, S., Schwinn, H., Josic, D., Stadler, M., Bal, F., Gehringer, W., Schutz, R. Development and biochemical characterization of a double-virus-inactivated factor VIII preparation (1995) Blood Coagulation and Fibrinolysis, 6 (SUPPL. 2), pp. S40-S47. Cited 1 times. Impact factor 1.408

119. Josic, D., Lim, Y.-P., Strancar, A., Reutter, W. Application of high-performance membrane chromatography for separation of annexins from the plasma membranes of liver and isolation of monospecific polyclonal antibodies (1994) Journal of Chromatography B: Biomedical Applications, 662 (2), pp. 217-226. Cited 35 times. Impact factor 2.971

120. Josic, D., Schwinn, H., Stadler, M., Strancar, A. Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography (1994) Journal of Chromatography B: Biomedical Applications, 662 (2), pp. 181-190. Cited 18 times. Impact factor 2.971

121. Strancar, A., Raspor, P., Schwinn, H., Schutz, R., Josic, D. Extraction of Triton X-100 and its determination in virus-inactivated human plasma by the solvent-detergent method (1994) Journal of Chromatography A, 658 (2), pp. 475-481. Cited 17 times. Impact factor 4.194

122. Schwinn, H., Stadler, M., Josic, D., Bal, F., Gehringer, W., Nur, I., Schutz, R. A solvent/detergent treated, pasteurised and highly purified factor VIII concentrate (1994) Arzneimittel-Forschung/Drug Research, 44 (2), pp. 188-191. Cited 17 times. Impact factor 0.632

123. Luksa, J., Menart, V., Milicic, S., Kus, B., Gaberc-Porekar, V., Josic, D. Purification of human tumour necrosis factor by membrane chromatography (1994) Journal of Chromatography A, 661 (1-2), pp. 161-168. Cited 32 times. Impact factor 4.194

124. Josic, D., Bal, F., Schwinn, H. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography (1993) Journal of Chromatography, 632 (1-2), pp. 1-10. Cited 30 times. Impact factor 4.194

125. Josic, D., Reusch, J., Loster, K., Baum, O., Reutter, High-performance membrane chromatogrpahy of serum and plasma membrane proteins (1992) Journal of Chromatography, 590 (1), pp. 59-76. Cited 100 times. Impact factor 4.194

126. Löster, K., Josic, Dj., Reusch, J. (1992), Nachweis verschiedener Isoformen monoklonaler Antikörper durch Hydroxylapatit-HPLC, GIT Spezial, Chromatographie 12, 104-106. Impact factor 1.075

127. Fan, H, Lim, YP, Josic, D, Lucka, L, Reutter, W (1991) Tissue-specific regulation of rat annexin-VI expression during development, BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 372 (9) 652-652. Impact factor 5.328

128. AbourebYeh, H, Josic, D, Gottschall, K, Schubert Rehberg, K, Korber, F (1991) Purification of carbonic-anhydrase isoenzymes by high-performance affinity-chromatography and hydrophobic interaction chromatography, JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1ST INTERNATIONAL SYMP ON APPLICATIONS OF HPLC IN ENZYME CHEMISTRY, SEP 18-21, 1990, VERONA, ITALY, 566 (2) 351-359. Cited 4 times. Impact factor 4.194

129. Josic, Dj., Reutter, W. (1991), Sample Preparation and Application of Different HPLC Methods for the Separation of Hydrophobic Membrane Proteins (Hodges, R. S., ed.), CRC Press, Boca Raton, 231-238.

130. Josic, Dj., Becker, A., Reutter, W. (1991), Application of HPA-Chromatographic Techniques, in "HPLC of Proteins, Peptides and Polynucleotides" (M. Hearn, ed.), VCh, Weinheim-New York, 469-494.

131. Abou-Rebyeh, H., Josić, Dj., Gottschall, K., Schubert-Rehberg, K.,Körber, F. (1991), Purification of Carbonic Anhydrase Isoenzymes by High Performance Affinity Chromatography and Hydrophobic Interaction Chromatography, J. Chromatogr. 566, 351-359. Cited 60 times. Impact factor 4.194

132. Josic, Dj., Löster, K., Kuhl, R., Noll, F., Reusch, J. (1991), Purification of Monoclonal Antibodies by Hydroxylapatite HPLC and Size Exclusion HPLC, Biol. Chem. Hoppe-Seyler 372, 149-156. Cited 16 times. Impact factor 3.603

133. Josic, D., Zeilinger, K., Reutter, W., Bottcher, A., Schmitz, G. High-performance capillary electrophoresis of hydrophobic membrane proteins (1990) Journal of Chromatography, 516 (1), pp. 89-98. Cited 11 times. Impact factor 4.194


©hrzz

12

134. Josic, D, Bottcher, A, Schmitz, G (1990) High-performance capillary isotachophoresis of serum-lipoproteins and membrane-proteins, CHROMATOGRAPHIA, 30 (11-12) 703-706. TC 8

135. Josic, D, Zeilinger, K, Reutter, W, Bottcher, A, Schmitz, G (1990) High-performance capillary electrophoresis of hydrophobic membrane-proteins, JOURNAL OF CHROMATOGRAPHY, 2ND INTERNATIONAL SYMP ON HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS (HPCE 90 ), JAN 29-31, 1990, SAN FRANCISCO, CA, 516 (1) 89-98. TC 22

136. Fan, H, Josic, D, Lim, YP, Lucka, L, Reutter, W (1990) cDNA cloning and primary structure of rat calcium-binding protein-65/67 KDa and its expression in different organs, BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 371 (9) 759-760. Cited 2 times. Impact factor 5.328

137. Lim, YP, Gossrau, R, Siegel, G, Josic, D, Reutter, W (1990) Characterization of calcium-binding proteins CBP-65/67, CBP-33 AND CBP-35, BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 371 (9) 763-763. Cited 0 times. Impact factor 5.328

138. Josic, D, Gossrau, R, Habermann, R, Lim, YP, Reutter, W (1990) Calcium-binding protein-33 KDa, protein-35 KDa, and protein-65/67 KDa in normal rat and morris hepatoma tissues - a biochemical and immunohistochemical study, HISTOCHEMISTRY, 93 (4) 389-395. Cited 11 times. Impact factor 4.727

139. Nuck, R, Zimmermann, M, Sauvageot, D, Josic, D, Reutter, W (1990) Optimized deglycosylation of glycoproteins by peptide-N-4-(N-acetyl-beta-glucosaminyl)-asparagine amidase from Flavobacterium-meningosepticum, GLYCOCONJUGATE JOURNAL, 7 (4) 279-286. Cited 29 times. Impact factor 2.700

140. Josic, Dj., Reusch, J. (1990), Reinigung und Isolierung von biologischen Proben mit Affinitätschromatographie, Chemische Rundschau 43 (Nr. 14), 15. Impact factor 1.950

141. Josic, D., Zeilinger, K., Lim, Y.-P., Raps, M., Hofmann, W., Reutter, W. Preparative isolation of glycoproteins from plasma membranes of different rat organs (1989) Journal of Chromatography, 484, pp. 327-335. Cited 14 times. Impact factor 4.194

142. Josic, Dj., Lim, Y.-P., Zeilinger, K., Raps, M., Hofmann, W., Reutter, W., (1989), Anwendung präparativer und analytischer Hochleistungsflüssig- keitschromatographie für die Trennung von Membranproteinen, 10. Königsteiner Chromatographie-Tage, Nürnberg, Vortragsband, 122-138.

143. Josic, D., Reutter, W., Reusch, J. Crown ethers as ligands for high-performance liquid chromatography of proteins and nucleic acids (1989) Journal of Chromatography, 476, pp. 309-318. Cited 4 times. Impact factor 4.194

144. Josic, Dj., Zeilinger, K. (1989), Hochleistungskapillarelektrophorese von Proteinen und Peptiden, Labor-Praxis 12, 1111-1114.

145. Josic, D., Hofmann, W., Habermann, R., Reutter, W. High-performance concanavalin a affinity chromatography of liver and hepatoma membrane proteins (1988) Journal of Chromatography, 444, pp. 29-39. Cited 11 times. Impact factor 4.194

146. Josic, D., Hofmann, W., Habermann, R., Schulzke, J.-D., Reutter, W. Isolation of immunoglobulins and their use in immunoaffinity HPLC (1988) Journal of Clinical Chemistry and Clinical Biochemistry, 26 (9), pp. 559-568. Cited 13 times. Impact factor 2.069

147. Josic, Dj., Raps, M., Hartel-Schenk, S., Hofmann, W., Reutter, W. (1988), Semipräparative Isolierung von Dipeptidyl Peptidase IV aus Leberplasma-membranen, 3. Würzburger Chromatographie-Gespräche, Würzburg 1988, 3-8.

148. Josic, D., Tauber, R., Hofmann, W., Mauck, J., Reutter, W. Half-lives of L-[35S]methionine and L-[3H]fucose of transferrin in the serum of rats (1987) Journal of Clinical Chemistry and Clinical Biochemistry, 25 (12), pp. 869-871. Cited 4 time. Impact factor 2.069

149. Josic, Dj. (1987), Affinitäts-HPLC von Proteinen, Labor-Praxis 4

150. Josić, D., Hofmann, W., Habermann, R., Becker, A., Reutter, W. High-performance liquid affinity chromatography of liver plasma membrane proteins (1987) Journal of Chromatography A, 397 (C), pp. 39-46. Cited 10 times. Impact factor 4.194

151. Josic, D., Hofmann, W., Reutter, W. Ion-exchange and hydrophobic-interaction high-performance liquid chromatography of proteins. A practical study (1986) Journal of Chromatography, Vol. 371, pp. 43-54. Cited 11 time. Impact factor 4.194

152. Josic, Dj. (1986), Anionenaustausch-HPLC von Proteinen, Labor-Praxis 3.

153. Mattia, E., Josic, D., Ashwell, G. Regulation of intracellular iron distribution in K562 human erythroleukemia cells (1986) Journal of Biological Chemistry, 261 (10), pp. 4587-4593. Cited 49 times. Impact factor 5.328


©hrzz

13

154. Tauber, R., Schenck, I., Josić, D., Gross, V., Heinrich, P.C., Gerok, W., Reutter, W. Different oligosaccharide processing of the membrane-integrated and the secretory form of gp 80 in rat liver. (1986) The EMBO journal, 5 (9), pp. 2109-2114. Cited 1 time. Impact factor 10.124

155. Josic, D., Schutt, W., Van Renswoude, J. High-performance liquid chromatographic methods for antibodies, glycosidases and membrane proteins (1986) Journal of Chromatography, VOL. 353, pp. 13-18. Cited 15 times. Impact factor 4.194

156. Josic, D., Mattia, E., Ashwell, G., Van Renswoude, J. Quantitative determination of intracellular, ferritin-associated radioactive iron by high-performance liquid chromatography and immunoprecipitation (1986) Analytical Biochemistry, 152 (1), pp. 42-47. Cited 7 times. Impact factor 3.236

157. Josic, D., Hofmann, W., Wieland, B. Anion-exchange high-performance liquid chromatography of membrane proteins from liver and Morris hepatomas (1986) Journal of Chromatography, VOL. 359, pp. 315-322. Cited 12 times. Impact factor 4.194

158. Josic, Dj., Schütt, W., Neumeier, R., Reutter, W. (1985), Purification of Liver and Hepatoma Membrane Proteins by High Performance Liquid Chromatography, FEBS Lett. 185, 182-186. Impact factor 3.601

159. Josic, D., Hofermaas, R., Bauer Ch., Reutter, W. Automatic amino acid and sugar analysis of glycoproteins (1984) Journal of Chromatography, VOL. 317, pp. 35-39. Cited 3 times. Impact factor 4.194

160. Neumeier, R., Josic, D., Reutter, W. Integral membrane antigens involved in cell-substratum adhesion of hepatocytes and hepatoma cells (1984) Experimental Cell Research, 151 (2), pp. 567-572. Impact factor 3.609

161. Josic, Dj., Baumann, H., Reutter, W. (1984), Size-Exclusion High Performance Liquid Chromatography and Sodium Dodecyl Sulfate-Poly-Acrylamide Gel Electrophoresis of Proteins: A Comparison, Anal. Biochem. 142, 473-479. Impact factor 3.236

162. Josic, Dj., Neumeier, R.; Reutter, W. (1983), Different Pattern of Membrane Components in Hepatocytes and Hepatoma Cells, Eur. J. Cell Biol., Suppl. 2, 20. Impact factor 3.630

163. Josic, Dj., Johanides, V. (1982), Die Roll der Emulgatoren in der Backhefetechnologie (Croatian), Kemija u industriji 30 (2), 69-75.

164. Josic, Dj. (1982), Optimization of Process Conditions for the Production of Active Dry Yeast, Lebensmittel-Wissenschaft und -Technologie 15, 5-14.

165. Josic, Dj., Reutter, W., Molnar, I. (1982), HPLC of Membrane Bound Proteins; Practical Aspects of Modern HPLC (I. Molnar, Ed.,), 109-121, Walter de Gruyter, Berlin - New York.

166. Josic, Dj. (1982), Hochleistungsflüssigkeitschromatographie (Croatian), Prehrambeno-tehnoloska revija 20 (2), 133-141.

167. Josic, Dj., Johanides, V. (1982), Die Roll der Emulgatoren in der Backhefetechnologie (Croatian), Kemija u industriji 30 (2), 69-75.

168. Josic, Dj. (1982), Optimization of Process Conditions for the Production of Active Dry Yeast, Lebensmittel-Wissenschaft und -Technologie 15, 5-14.

169. Josic, Dj., Reutter, W., Molnar, I. (1982), HPLC of Membrane Bound Proteins; Practical Aspects of Modern HPLC (I. Molnar, Ed.,), 109-121, Walter de Gruyter, Berlin - New York.

170. Josic, Dj. (1982), Hochleistungsflüssigkeitschromatographie (Croatian), Prehrambeno-tehnoloska revija 20 (2), 133-141.

171. Josic, Dj. (1980), Kriterien zur Qualitätsbestimmung der aktiven Trockenbackhefe, in "Getreide, Mehl und Brot" 34, 179-182.

172. Josic, Dj. (1980), Moderne Tendenzen in der Entwicklung der Backhefe- technologie (Croatian), Kemija u industriji 29, 177-182.

173. Josic, Dj. (1980), Kriterien zur Qualitätsbestimmung der aktiven Trockenbackhefe, in "Getreide, Mehl und Brot" 34, 179-182.

174. Josic, Dj. (1980), Moderne Tendenzen in der Entwicklung der Backhefe- technologie (Croatian), Kemija u industriji 29, 177-182.

175. Reuss, M., Josic, Dj., Popovic, M., Bronn, W.K. (1979), Viscosity of Yeast Suspensions, Eur. J. Appl. Microbiol. Biotechnol. 8, 167-172. Impact factor 3.583

176. Reuss, M., Josic, Dj., Popovic, M., Bronn, W.K. (1979), Viscosity of Yeast Suspensions, Eur. J. Appl. Microbiol. Biotechnol. 8, 167-172. Impact factor 3.583

PATENTS

1. Schuhmacher, W., Reusch, J., Kaleja, M. and Josic, D., 1991. "Probenverteiler". DE 4118501A1. Germany.


©hrzz

14

2. Josic, Dj., Strancar A and Schwinn H, 1993, “Verfahren zur Herstellung virusinactivierter Vitamin K abhangiger Plasmakomponenten wie Protein C und Protein S erhaltender Mittel durch Membranchromatographie”. DE 4342132, Germany.

3. Josic, D., Strancar, A. and Schwinn, H., 1993. "Verfahren zur Herstellung virusinaktivierter Vitamin K abhängiger Plasmakomponenten wie Protein C und Protein S erhaltender Mittel durch Membranchromatographie". DE 4342132. Germany.

4. Josic, D., Strancar, A. and Schwinn, H., 1993. "Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden". DE 4337573.1 Germany.

5. Stadler, M., Schwinn, H., Josic, D., Gehringer, W. and Bal, F., 1993. “Verfahren zur Inaktivierung von Viren, die nicht mit Lipidhüllen versehen sind”. DE 4318435A1. Germany.

6. Josic, D., Strancar, A. and Nur, I., 1994. “Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Alpha-1-Antitrypsin mittels Anionenaustauscherchromatographie”. P 4407837.4 Germany.

7. Hoffer, L, Morfeld, F., Schwinn, H. and Josic, D., 1995. "Verfahren zur Herstellung von Faktor IX aus biologischen Quellen". DE 19506633.2. Germany.

8. Josic, D., Strancar, A., Koselj, P. and Podgornik, A., 1995. "Process device for the rapid separation and/or conversion of substrates". PCT/EP 95/03333. European Patent.

9. Morfeld, F., Hoffer, L., Schwinn, H. and Josic, D., 1995. "Verfahren zur Reinigung Vitamin K-abhängiger Gerinnungsfaktoren durch Chromatographie". DE 19504852.0. Germany.

10. Josic, D. and Strancar, A., 1995. “Purification of vitamin-k dependent proteins by membrane chromatography”. WO 95/16030. International Patent.

11. Buchacher, A., Stadler, M., Josic, D. and Schwinn, H., 1997. “Process for testing suitability of protein fractions containing factor VIII”. WO 97/33178. International Patent.

12. Buchacher, A., Josic, D., Gruber, G., Prior, A. and Wolfgang, J., 1999. “Method for separating and/or isolating plasma proteins by annularchromatography”. WO 99/61475. International Patent.

13. Josic, D., Biesert, L., Klengel, R.W.K., Buchacher, A. and Schwinn, H., 2000. “Verfahren zur Entfernung oder Abtrennung von Viren in potentiell Viren enthaltenden Proben.” DE 19926041 A1. Germany.

14. Strancar, A, Podgornik, A, Barut, M, Josic, D., 2000. “Process and device for the rapid separation and/or conversion of substrates”. US Patent 6,319,401

15. Josic, D., 2001, “Bikunin containing Plasmafraction, Method of Production and Application”. European Patent Application PCT/EP01/11994.

16. Jungbauer, A, Necina, R Josic, D, 1999. “Peptide having affinity for Coagulation Factor VIII”. US Patent application No. 09/535,529. 27.03.2000. International Patent Application WO 99/14232. 25.03.99

DRUGE ZNANSTVENE AKTIVNOSTI (KRONOLOŠKI; UREDNIK ILI ČLAN UREĐIVAČKOG ODBORA ZNANSTVENE KNJIGE, DOMAĆIH I MEĐUNARODNIH ZNANSTVENIH ČASOPISA, ZBORNIKA

RADOVA DOMAĆIH I MEĐUNARODNIH ZNANSTVENIH SKUPOVA I DRUGO)

1998. - 2008. u uredničkom odboru znanstvenog časopisa Food Technology and Biotechnology

od 2000. urednik specijalnih izdanja znanstvenog časopisa Journal of Chromatography A

od 2009. u uredničkom odboru znanstvenog časopisa Electrophoresis

od 2009. urednik International Journal of Proteomics

2011. Izdavač «Liver proteomics», in Methods of Molecular Biology, Humana Press

2011. urednik specialnog broja znanstvenog časopisa Food Technology and Biotechnology, «Proteomics in Food Technology and Biotechnology»

POZNAVANJE RADA NA RAČUNALU

Poznavanje svih programa potrebnih za znanstveni rad i objavljivanje u međunarodnim časopisima.

OSTALE VAŽNE VJEŠTINE I KOMPETENCIJE

Iskustvo u industriji (14 godina na vodećim položajima).


©hrzz

15

DODATNI PODATCI I NAPOMENE

Professor Josic performed pioneering work in development of protein separation, especially on separation of membrane proteins and other glycoproteins by use of different compatible chromatographic supports. Two early publications about the use of monolithic supports (this time still called “membranes”) for separation of serum and membrane proteins as well as fast enzymatic conversion of low- and macromolecular substrates were cited for about 200 times. Already this time, the use of monolithic supports for very fast chromatographic separations and enzymatic conversion in seconds was discovered. Prof. Josic continued working on applications of monoliths for preparative separation of therapeutic proteins and membrane glycoproteins. Recent work was focused on proteomic and glycomic investigations, and high-throughput isolation of high- and low abundant proteins from complex biological mixtures, such as serum, plasma, food and microbial samples, and development of label-free quantitative proteomics. Professor Josic is editor and member of the editorial board of several peer-reviewed journals, and has published more than 170 scientific papers and more than 20 patents.

Documents

Životopis obrazac HRZZ - labp.biotech.uniri.hrlabp.biotech.uniri.hr/files/CV Josic.pdf · Životopis_obrazac_HRZZ ©hrzz 3 1981-1991. – Medicinska biokemija, preddiplomska, dodiplomska,